What are Elanco Animal Health Inc.'s total assets?

Elanco Animal Health Inc. (ELAN) holds $13.2B in total assets, up 2.2% year over year.

How much debt does Elanco Animal Health Inc. have?

Elanco Animal Health Inc. carries $4.3B in total debt against $6.5B of shareholders' equity, a debt-to-equity ratio of 0.66.

How much cash does Elanco Animal Health Inc. have?

Elanco Animal Health Inc. holds $428.0M in cash and equivalents.

Can Elanco Animal Health Inc. cover its short-term obligations?

Its current ratio is 2.16 — current assets exceed current liabilities.

Where does Elanco Animal Health Inc.'s balance sheet data come from?

Every line is extracted from Elanco Animal Health Inc.'s SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.

Elanco Animal Health Inc. ELAN Balance Sheet Statement

Income Statement Balance Sheet Cash Flow Ratios Segments

Quarterly Annual TTM

YoY QoQ

Simplified Detailed

	Q1 '26	Q4 '25	Q3 '25	Q2 '25	Q1 '25
Cash and cash equivalents	$428M-12.1%	$545M+16.5%	$505M+3.1%	$539M+29.6%	$487M+41.2%
Accounts receivable, net	$1.08B+11.8%	$873M+8.4%	$894M+6.4%	$989M-1.0%	$970M-1.8%
Inventories	$1.79B+8.0%	$1.81B+10.8%	$1.78B+5.3%	$1.74B+4.1%	$1.66B-2.5%
Raw materials	$112M+16.7%	$104M+6.1%	$117M+11.4%	$98M-10.1%	$96M-11.9%
Work in process	$800M-2.2%	$837M+6.9%	$814M+4.5%	$826M+4.8%	$818M+2.8%
Finished goods	$879M+18.0%	$871M+15.5%	$853M+5.2%	$819M+5.4%	$745M-6.5%
Prepaid expenses and other current assets	$285M-5.3%	$236M-17.8%	$305M-10.3%	$302M+9.0%	$301M-10.9%
Total current assets	$3.58B+4.2%	$3.46B+7.6%	$3.49B+3.8%	$3.61B-9.9%	$3.44B-15.1%
Property and equipment, net	$1.4B+33.2%	$1.41B+41.9%	$1.39B+42.2%	$1.36B+43.0%	$1.05B+10.3%
Goodwill	$4.72B+4.8%	$4.78B+8.3%	$4.76B+3.0%	$4.76B+6.2%	$4.51B+0.7%
Intangible assets, net	$3.23B-11.3%	$3.41B-7.4%	$3.6B-10.3%	$3.71B-7.4%	$3.63B-13.4%
Other non-current assets	$295M-5.4%	$304M-2.3%	$306M+1.3%	$308M-4.9%	$312M-9.8%
Equity method investments	$13M-13.3%	$15M-11.8%	$15M-40.0%	$14M-41.7%	$15M-40.0%
Total assets	$13.22B+2.2%	$13.36B+5.9%	$13.55B+2.0%	$13.74B-0.2%	$12.94B-7.7%
Accounts payable	$372M+12.7%	$368M+24.3%	$352M+35.9%	$368M+26.5%	$330M+9.3%
Accrued expenses	$817M+41.8%	$739M+318%	$665M-2.9%	$596M+16.9%	$576M+0.3%
Deferred revenue	$400M+25.4%	$416M+25.3%	$376M+12.9%	$367M+3.1%	$319M+0.3%
Current portion of long-term debt	$73M+65.9%	$74M+68.2%	$62M+40.9%	$61M-71.4%	$44M+15.8%
Finance Lease Liability, Current	——	$16M—	——	——	——
Contract liabilities	$400M+25.4%	$416M+25.3%	$376M+12.9%	$367M+3.1%	$319M+0.3%
Total current liabilities	$1.66B+31.0%	$1.6B+21.4%	$1.46B+10.1%	$1.39B+1.6%	$1.27B+3.0%
Long-term debt	$3.99B-8.3%	$4.02B-7.0%	$4.02B-6.7%	$4.21B-23.0%	$4.35B-24.0%
Finance Lease Liabilities (Total)	$255M—	$255M—	$255M—	$255M—	——
Finance lease liabilities	$255M—	$239M—	$255M—	$255M—	——
Other non-current liabilities	$467M-4.1%	$585M+93.7%	$607M+3.4%	$638M+37.2%	$487M+2.7%
Total liabilities	$6.72B+2.0%	$6.81B+4.5%	$6.8B+0.6%	$6.97B-10.9%	$6.59B-17.3%
Preferred stock	$0—	$0—	——	——	——
Common stock	5B0.0%	5B—	5B0.0%	5B0.0%	5B0.0%
Additional paid-in capital	$8.86B+0.4%	$8.87B+0.6%	$8.85B+0.6%	$8.84B+0.6%	$8.82B+0.5%
Retained earnings	-$2.13B-12.9%	-$2.18B-11.9%	-$1.91B+1.9%	-$1.87B+18.8%	-$1.88B+16.5%
Accumulated other comprehensive income (loss)	-$233M+60.0%	-$141M+81.7%	-$199M+41.3%	-$192M+64.6%	-$583M-25.4%
Total stockholders' equity	$6.5B+2.3%	$6.55B+7.4%	$6.75B+3.5%	$6.78B+14.0%	$6.35B+4.9%
Total liabilities and stockholders' equity	$13.22B+2.2%	$13.36B+5.9%	$13.55B+2.0%	$13.74B-0.2%	$12.94B-7.7%
Other accounts receivable (net of allowances of $37 in 2026 and $37 in 2025)	$70M-22.2%	$67M-17.3%	$81M+26.6%	$114M+40.7%	$90M0.0%
Raw materials and supplies inventory, gross	$112M+16.7%	$104M+6.1%	$117M+11.4%	$98M-10.1%	$96M-11.9%
Inventory LIFO Reserve	$74M+10.4%	$75M+23.0%	$76M+20.6%	$73M+15.9%	$67M+4.7%
Other Receivables	$70M-22.2%	$67M-17.3%	$81M+26.6%	$114M+40.7%	$90M0.0%
Deferred Tax Assets and Other Non-Current Assets	$295M-5.4%	$304M-2.3%	$306M+1.3%	$308M-4.9%	$312M-9.8%
Other intangible assets—net	$3.23B-11.3%	$3.41B-7.4%	$3.6B-10.3%	$3.71B-7.4%	$3.63B-13.4%
Other non-current assets	$295M-5.4%	$304M-2.3%	$306M+1.3%	$308M-4.9%	$312M-9.8%
Property, plant and equipment, net	——	$1.41B+41.9%	——	——	——
Software and Technology Licenses, Net	$295M-5.4%	$304M-2.3%	$306M+1.3%	$308M-4.9%	$312M-9.8%
Accrued Litigation	$0—	$0—	$0—	$0—	$0—
Other accrued liabilities	$817M+41.8%	$739M+58.6%	$665M-2.9%	$596M+16.9%	$576M+0.3%
Current Portion of Long-Term Debt and Finance Lease Obligations	$73M—	$74M+68.2%	$62M—	$61M—	——
Restructuring Reserve	$102M—	$124M—	——	——	——
Debt Instrument - Effective Interest Rate	80%0.0%	——	80%-1.0%	89%—	80%+2.0%
Debt - Unamortized Discount (Premium) and Issuance Costs, Net	$27M+8.0%	$28M0.0%	$17M-43.3%	$21M-51.2%	$25M-45.7%
Long-Term Debt and Finance Lease Obligations	$3.92B—	$3.94B-7.8%	$3.96B—	$4.15B—	——
Total debt	$4.32B-1.7%	$4.47B-0.4%	$4.34B-0.4%	$4.53B-20.3%	$4.4B-23.8%
Common Stock Shares Issued	499.4M+0.6%	497M+0.5%	496.8M+0.5%	496.6M+0.5%	496.5M+0.5%
Convertible Preferred Stock Authorized Shares	1B—	1B—	——	——	——
Convertible Preferred Stock Issued Shares	0—	0—	——	——	——
Common stock; $0.001 par value; 6,000 shares authorized; 3,755 and 3,751 shares issued and outstanding as of March 31, 2026 and December 31, 2025, respectively	$0—	$0—	$0—	$0—	$0—
Preferred stock; $0.001 par value; 100 shares authorized; no shares issued and outstanding	$0—	$0—	——	——	——
Interest Rate Hedge Reclassification (Next 12 Months)	-$9M-200%	——	-$19M-154%	-$7M-108%	$9M-90.2%
Common stock, shares authorized (in shares)	$5B0.0%	$5B0.0%	$5B0.0%	$5B0.0%	$5B0.0%
Common stock, shares issued (in shares)	$499.38M+0.6%	$496.98M+0.5%	$496.83M+0.5%	$496.65M+0.5%	$496.46M+0.5%
Common Stock, Shares, Outstanding	$499.38M+0.6%	$496.98M+0.5%	$496.83M+0.5%	$496.65M+0.5%	$496.46M+0.5%
Contract with Customer, Liability	$400M+25.4%	$416M+25.3%	$376M+12.9%	$367M+3.1%	$319M+0.3%
Deferred income taxes	$366M-23.9%	$382M-14.9%	$478M-11.3%	$496M-5.3%	$481M-9.2%
Equity method investments (Note 11)	$13M-13.3%	$15M-11.8%	$15M-40.0%	$14M-41.7%	$15M-40.0%
Current maturities of long-term debt	——	$16M—	——	——	——
Gains expected to be reclassified	-$9M-200%	——	-$19M-154%	-$7M-108%	$9M-90.2%
Estimated litigation liability	$0—	$0—	$0—	$0—	$0—
Long-Term Debt and Lease Obligation	$3.92B—	$3.94B-7.8%	$3.96B—	$4.15B—	——
Less: current maturities	$73M—	$74M+68.2%	$62M—	$61M—	——
Preferred Stock, Shares Authorized	$1B—	$1B—	——	——	——
Preferred Stock, Shares Issued	$0—	$0—	——	——	——
Restructuring Reserve	$102M—	$124M—	——	——	——
Liability for sale of future revenue	$309M—	$304M—	$300M—	$293M—	——

Chart any of these lines over time, or line them up against competitors.

Compare these in charts →

Ask your AI about Elanco Animal Health Inc..

Connect your AI assistant and get a quick read on the numbers, right in your chat.

Connect your AI

Claude

Questions, answered.

What are Elanco Animal Health Inc.'s total assets?: Elanco Animal Health Inc. (ELAN) holds $13.2B in total assets, up 2.2% year over year.
How much debt does Elanco Animal Health Inc. have?: Elanco Animal Health Inc. carries $4.3B in total debt against $6.5B of shareholders' equity, a debt-to-equity ratio of 0.66.
How much cash does Elanco Animal Health Inc. have?: Elanco Animal Health Inc. holds $428.0M in cash and equivalents.
Can Elanco Animal Health Inc. cover its short-term obligations?: Its current ratio is 2.16 — current assets exceed current liabilities.
Where does Elanco Animal Health Inc.'s balance sheet data come from?: Every line is extracted from Elanco Animal Health Inc.'s SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.